Åsa Nordling

1.9k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Åsa Nordling is a scholar working on Pharmacology, Oncology and Hepatology. According to data from OpenAlex, Åsa Nordling has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Oncology and 6 papers in Hepatology. Recurrent topics in Åsa Nordling's work include Pharmacogenetics and Drug Metabolism (7 papers), Liver physiology and pathology (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Åsa Nordling is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Liver physiology and pathology (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Åsa Nordling collaborates with scholars based in Sweden, United Kingdom and Netherlands. Åsa Nordling's co-authors include Magnus Ingelman‐Sundberg, Inger Johansson, Volker M. Lauschke, Delilah Hendriks, Souren Mkrtchian, B. Kevin Park, Sabrina Moro, Rowena Sison‐Young, Catherine C. Bell and Ewa Ellis and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Åsa Nordling

15 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease

2016 517 citations Catherine C. Bell, Delilah Hendriks et al. Scientific Reports profile →

Peers

Countries citing papers authored by Åsa Nordling

Since Specialization

Citations

This map shows the geographic impact of Åsa Nordling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åsa Nordling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åsa Nordling more than expected).

Fields of papers citing papers by Åsa Nordling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Åsa Nordling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åsa Nordling. The network helps show where Åsa Nordling may publish in the future.

Co-authorship network of co-authors of Åsa Nordling

This figure shows the co-authorship network connecting the top 25 collaborators of Åsa Nordling. A scholar is included among the top collaborators of Åsa Nordling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Åsa Nordling. Åsa Nordling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Mechanisms of 5-HT receptor antagonists in the regulation of fibrosis in a 3D human liver spheroid model 2024 ·Scientific Reports ·(unknown), Sander van Riet, Åsa Nordling, Magnus Ingelman‐Sundberg	4
2	The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model 2024 ·Hepatology Communications ·Sander van Riet, Anaïs Julien, (unknown), Åsa Nordling, Magnus Ingelman‐Sundberg	8
3	Mechanistic, Functional, and Clinical Aspects of Pro‐inflammatory Cytokine Mediated Regulation of ADME Gene Expression in 3D Human Liver Spheroids 2023 ·Clinical Pharmacology & Therapeutics ·Katharina Klöditz, (unknown), Åsa Nordling, Magnus Ingelman‐Sundberg	8
4	The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids 2023 ·Cells ·(unknown), Sander van Riet, Åsa Nordling, Magnus Ingelman‐Sundberg	17
5	Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis 2020 ·Cells ·Tracey Hurrell, (unknown), (unknown), Delilah Hendriks, Åsa Nordling, Inger Johansson, Audrey Baze, C. Parmentier, Lysiane Richert, Magnus Ingelman‐Sundberg	56
6	Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three‐Dimensional Spheroid Cultures of Primary Human Hepatocytes 2020 ·Clinical Pharmacology & Therapeutics ·Delilah Hendriks, Sabine U. Vorrink, Tomáš Smutný, Sarah C. Sim, Åsa Nordling, Shahid Ullah, Masaki Kumondai, Barry Jones, Inger Johansson, Tommy B. Andersson, Volker M. Lauschke, Magnus Ingelman‐Sundberg	41
7	CYP3A5 is Unlikely to Mediate Anticancer Drug Resistance in Hepatocellular Carcinoma 2019 ·Pharmacogenomics ·Volker M. Lauschke, Åsa Nordling, Yitian Zhou, (unknown), Isabel Barragán, Magnus Ingelman‐Sundberg	2
8	Human hepatic 3D spheroids as a model for steatosis and insulin resistance 2018 ·Scientific Reports ·(unknown), Inger Johansson, Åsa Nordling, Shahid Ullah, Volker M. Lauschke, Magnus Ingelman‐Sundberg	129
9	Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease breakdown → 2016 ·Scientific Reports ·Catherine C. Bell, Delilah Hendriks, Sabrina Moro, Ewa Ellis, Joanne Walsh, (unknown), (unknown), Anita C. A. Dankers, Frank Jacobs, Jan Snoeys, Rowena Sison‐Young, Rosalind E. Jenkins, Åsa Nordling, Souren Mkrtchian, B. Kevin Park, Neil R. Kitteringham, Christopher E. Goldring, Volker M. Lauschke, Magnus Ingelman‐Sundberg	517
10	Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiation 2016 ·Hepatology ·Volker M. Lauschke, Sabine U. Vorrink, Sabrina Moro, Fatemah Rezayee, Åsa Nordling, Delilah Hendriks, Catherine C. Bell, Rowena Sison‐Young, B. Kevin Park, Christopher E. Goldring, Ewa Ellis, Inger Johansson, Souren Mkrtchian, Tommy B. Andersson, Magnus Ingelman‐Sundberg	95
11	Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran 2015 ·PLoS ONE ·Etienne P.A. Neve, Harald Köfeler, Delilah Hendriks, Åsa Nordling, Vladimir Gogvadze, Souren Mkrtchian, Erik Näslund, Magnus Ingelman‐Sundberg	24
12	Sex Difference in Formation of Propofol Metabolites: A Replication Study 2013 ·Basic & Clinical Pharmacology & Toxicology ·Eva Choong, Irena Loryan, M. Lindqvist, Åsa Nordling, Samira El Bouazzaoui, Ron HN van Schaik, Inger Johansson, Jan Jakobsson, Magnus Ingelman‐Sundberg	43
13	Amidoxime Reductase System Containing Cytochrome b5 Type B (CYB5B) and MOSC2 Is of Importance for Lipid Synthesis in Adipocyte Mitochondria 2011 ·Journal of Biological Chemistry ·Etienne P.A. Neve, Åsa Nordling, Tommy B. Andersson, Ulf Hellman, Ulf Diczfalusy, Inger Johansson, Magnus Ingelman‐Sundberg	48
14	CHARACTERIZATION AND PARTIAL PURIFICATION OF THE RAT AND HUMAN ENZYME SYSTEMS ACTIVE IN THE REDUCTION OF N-HYDROXYMELAGATRAN AND BENZAMIDOXIME 2005 ·Drug Metabolism and Disposition ·(unknown), Yvonne Hofmann, Åsa Nordling, Xueqing Li, (unknown), Tommy B. Andersson, Magnus Ingelman‐Sundberg, Inger Johansson	31
15	Zonation of cytochrome P450 isozyme expression and induction in rat liver 1992 ·European Journal of Biochemistry ·Rolf Bühler, (unknown), Åsa Nordling, Inger Johansson, Magnus Ingelman‐Sundberg	102

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact